WO2003023060A3 - Verfahren und kit zur diagnostik oder behandlungskontrolle von brustkrebs - Google Patents
Verfahren und kit zur diagnostik oder behandlungskontrolle von brustkrebs Download PDFInfo
- Publication number
- WO2003023060A3 WO2003023060A3 PCT/EP2002/009999 EP0209999W WO03023060A3 WO 2003023060 A3 WO2003023060 A3 WO 2003023060A3 EP 0209999 W EP0209999 W EP 0209999W WO 03023060 A3 WO03023060 A3 WO 03023060A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- diagnosing
- kit
- treatment
- controlling
- breast cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/488,828 US20050014208A1 (en) | 2001-09-06 | 2002-09-06 | Method and kit for diagnosing or controlling the treatment of breast cancer |
EP02774579A EP1409746A2 (de) | 2001-09-06 | 2002-09-06 | Verfahren und kit zur diagnostik oder behandlungskontrolle von brustkrebs |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10143776.5 | 2001-09-06 | ||
DE10143776A DE10143776A1 (de) | 2001-09-06 | 2001-09-06 | Verfahren und Kit zur Diagnostik oder Behandlungskontrolle von Brustkrebs |
EPPCT/EP02/05489 | 2002-05-17 | ||
PCT/EP2002/005489 WO2003023057A2 (de) | 2001-09-06 | 2002-05-17 | Verfahren und diagnose-kit zur selektionierung und/oder zum qualitativen und/oder quantitativen nachweis von zellen |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003023060A2 WO2003023060A2 (de) | 2003-03-20 |
WO2003023060A3 true WO2003023060A3 (de) | 2004-01-29 |
Family
ID=26010082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/009999 WO2003023060A2 (de) | 2001-09-06 | 2002-09-06 | Verfahren und kit zur diagnostik oder behandlungskontrolle von brustkrebs |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1409746A2 (de) |
WO (1) | WO2003023060A2 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4336198B2 (ja) | 2001-09-06 | 2009-09-30 | アトナーゲン アクチエンゲゼルシャフト | 細胞の選択、および/または定性および/または定量検出のための方法および診断キット |
CA2548394A1 (en) * | 2003-12-12 | 2005-06-30 | Bayer Pharmaceuticals Corporation | Methods for prediction and prognosis of cancer, and monitoring cancer therapy |
CA2576702C (en) * | 2004-08-11 | 2016-10-04 | Albert Einstein College Of Medicine Of Yeshiva University | Isolation, gene expression, and chemotherapeutic resistance of motile cancer cells |
JP2006223194A (ja) * | 2005-02-17 | 2006-08-31 | Tosoh Corp | スタニオカルシン1(STC1)mRNAの測定方法 |
WO2007048978A2 (fr) * | 2005-10-28 | 2007-05-03 | Biomerieux Sa | Procede de detection du cancer |
FR2899239A1 (fr) * | 2006-03-31 | 2007-10-05 | Biomerieux Sa | Procede de detection du cancer |
FR2892730A1 (fr) * | 2005-10-28 | 2007-05-04 | Biomerieux Sa | Methode pour detecter la presence ou le risque de developper un cancer |
EP2088204A1 (de) * | 2008-02-05 | 2009-08-12 | Adnagen AG | Verfahren und Kit zur Diagnose bzw. Kontrolle der Behandlung von Ovarialkarzinomen |
GB201000688D0 (en) * | 2010-01-15 | 2010-03-03 | Diagenic Asa | Product and method |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994007139A1 (en) * | 1992-09-14 | 1994-03-31 | Fodstad Oystein | Improved method for detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations |
DE19736691A1 (de) * | 1997-08-22 | 1999-02-25 | Michael Prof Dr Med Giesing | Verfahren zur Charakterisierung und Identifizierung disseminierter und metastasierter Krebszellen |
WO1999044064A1 (en) * | 1998-02-27 | 1999-09-02 | Cli Oncology, Inc. | Method and compositions for differential detection of primary tumor cells and metastatic cells |
-
2002
- 2002-09-06 EP EP02774579A patent/EP1409746A2/de not_active Ceased
- 2002-09-06 WO PCT/EP2002/009999 patent/WO2003023060A2/de not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994007139A1 (en) * | 1992-09-14 | 1994-03-31 | Fodstad Oystein | Improved method for detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations |
DE19736691A1 (de) * | 1997-08-22 | 1999-02-25 | Michael Prof Dr Med Giesing | Verfahren zur Charakterisierung und Identifizierung disseminierter und metastasierter Krebszellen |
WO1999044064A1 (en) * | 1998-02-27 | 1999-09-02 | Cli Oncology, Inc. | Method and compositions for differential detection of primary tumor cells and metastatic cells |
Non-Patent Citations (12)
Title |
---|
BALZAR M ET AL: "The biology of the 17-1A antigen (Ep-CAM)", JOURNAL OF MOLECULAR MEDICINE, SPRINGER VERLAG, DE, vol. 77, no. 10, October 1999 (1999-10-01), pages 699 - 712, XP000925817, ISSN: 0946-2716 * |
CHARPENTIER A H ET AL: "STC2 AND E2IG1, TWO NOVEL BREAST CANCER BIOMARKERS", PROCEEDINGS OF THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, NEW YORK, NY, US, vol. 42, no. 628, March 2001 (2001-03-01), pages 628, XP001119829, ISSN: 0197-016X * |
CHRYSOGELOS S A ET AL: "EGF RECEPTOR EXPRESSION, REGULATION, AND FUNCTION IN BREAST CANCER", BREAST CANCER RESEARCH AND TREATMENT, NIJHOFF, BOSTON, US, vol. 29, no. 1, 1994, pages 29 - 40, XP001118068, ISSN: 0167-6806 * |
COLTRERA MARC D ET AL: "Expression of Platelet-derived Growth Factor B-Chain and the Platelet-derived Growth Factor Receptor beta Subunit in Human Breast Tissue and Breast Carcinoma.", CANCER RESEARCH, vol. 55, no. 12, 1995, pages 2703 - 2708, XP001153992, ISSN: 0008-5472 * |
FUJIWARA Y ET AL: "ASSESSMENT OF STANNIOCALCIN-1 MRNA AS A MOLECULAR MARKER FOR MICROMETASTASES OF VARIOUS HUMAN CANCERS", INTERNATIONAL JOURNAL OF ONCOLOGY, EDITORIAL ACADEMY OF THE INTERNATIONAL JOURNAL OF ONCOLOGY,, GR, vol. 16, April 2000 (2000-04-01), pages 799 - 804, XP002938551, ISSN: 1019-6439 * |
GHOSSEIN R A ET AL: "Molecular detection of micrometastases and circulating tumor cells in solid tumors", CLINICAL CANCER RESEARCH, THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 5, no. 8, August 1999 (1999-08-01), pages 1950 - 1960, XP002225510, ISSN: 1078-0432 * |
HARDINGHAM J E ET AL: "IMMUNOBEAD-PCR: A TECHNIQUE FOR THE DETECTION OF CIRCULATING TUMOR CELLS USING IMMUNOMAGNETIC BEADS AND THE POLYMERASE CHAIN REACTION", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 53, 1 August 1993 (1993-08-01), pages 3455 - 3458, XP000605489, ISSN: 0008-5472 * |
MARTIN KATHERINE J ET AL: "High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 98, no. 5, 27 February 2001 (2001-02-27), pages 2646 - 2651, XP002188522, ISSN: 0027-8424 * |
NACHT MARIANA ET AL: "Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 59, no. 21, 1 November 1999 (1999-11-01), pages 5464 - 5470, XP002166291, ISSN: 0008-5472 * |
RACILA E ET AL: "Detection and charcterization of carcinoma cells in the blood", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 95, April 1998 (1998-04-01), pages 4589 - 4594, XP002132943, ISSN: 0027-8424 * |
SMITH B ET AL: "DETECTION OF MELANOMA CELLS IN PERIPHERAL BLOOD BY MEANS OF REVERSE TRANSCRIPTASE AND POLYMERASE CHAIN REACTION", LANCET THE, LANCET LIMITED. LONDON, GB, vol. 338, 16 November 1991 (1991-11-16), pages 1227 - 1229, XP002008751, ISSN: 0140-6736 * |
ZHONG X Y ET AL: "EVALUATING GA733-2 MRNA AS A MARKER FOR THE DETECTION OF MICROMETASTATIC BREAST CANCER IN PERIPHERAL BLOOD AND BONE MARROW", ARCHIVES OF GYNECOLOGY AND OBSTETRICS, SPRINGER VERLAG, BERLIN, DE, vol. 263, no. 1/2, 1999, pages 2 - 6, XP000929386, ISSN: 0932-0067 * |
Also Published As
Publication number | Publication date |
---|---|
EP1409746A2 (de) | 2004-04-21 |
WO2003023060A2 (de) | 2003-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TAHARA et al. | Human epidermal growth factor in gastric carcinoma as a biologic marker of high malignancy | |
MXPA03000527A (es) | Composiciones y metodos para la terapia y diagnostico de cancer ovarico. | |
AU2001272908A1 (en) | Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers | |
NZ512247A (en) | Compositions and methods for therapy and diagnosis of ovarian cancer | |
WO2002016413A8 (en) | Cripto tumour polypeptide | |
DE60045201D1 (de) | C-Typ-Lektin-Transmembran-Antigen, das in menschlichem Prostatakrebs exprimiert wird, und Verwendungen dieses Antigens | |
WO2001008636A8 (en) | Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein | |
ATE296839T1 (de) | Antikörper zur krebsbehandlung und -diagnose | |
WO2001040269A3 (en) | Compositions and methods for therapy and diagnosis of breast cancer | |
NZ330887A (en) | Monoclonals and polyclonals antibodies for the diagnosis of breast cancer | |
ATE229073T1 (de) | Protein e25a, methoden zu dessen herstellung und anwendung | |
WO2005001092A3 (en) | Compositions and methods for diagnosing and treating cancers | |
WO2003023060A3 (de) | Verfahren und kit zur diagnostik oder behandlungskontrolle von brustkrebs | |
NO174719C (no) | Fremgangsmåte for fremstilling av monoklonale antistoffer | |
WO2002078516A3 (en) | Compositions and methods for the therapy and diagnosis of cancer | |
WO2003023059A3 (de) | Verfahren und kit zur diagnostik oder behandlungskontrolle von darmkrebs | |
ES2101695T3 (es) | Haptoglobina relacionada con el cancer (hpr). | |
WO2003013431A3 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
EP1696028A3 (de) | Zusammensetzungen und Methoden zur Therapie und Diagnose von Brustkrebs | |
WO2000078960A3 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
EP0839908A3 (de) | ELF3, ein Mitglied der ETS-Familie | |
ATE475710T1 (de) | Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs | |
WO2005042578A3 (en) | Antibody fab fragment specific for breast cancer | |
DE60139150D1 (de) | Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs | |
WO1999043812A3 (en) | Dlc-1 gene, a putative tumors suppressor gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FR GB GR IE IT LU MC NL PT SE SK TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002774579 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002774579 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10488828 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |